We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 56

Pharmaceutical companies should be aware of the possibility that injunctions for patent infringement may be denied following Wuhan Jingyuan v Fujikasui, Huayang

  • Bird & Bird
  • -
  • China
  • -
  • January 31 2011

Foreign pharmaceutical companies enforcing their patent rights in China may have more to worry about following the Chinese Supreme Court Decision in Wuhan Jingyuan v Fujikasui, Huayang, in December 2009

Initial victory of a seven year battle for patent infringement

  • Lifang & Partners
  • -
  • China
  • -
  • January 2 2014

Rhodia, now part of the Solvay Group, is a French catalyst maker who found in 2006 that a Tianjin company produced and sold products infringing upon

China’s Patent Re-Examination Board says pharmaceutical salts not patentable over pure compounds

  • Greenberg Traurig LLP
  • -
  • China
  • -
  • August 14 2013

In July 2013, the Patent Re-Examination Board of China's State Intellectual Property Office invalidated the U.S. biotech company, Gilead Sciences'

Beijing High Court issues Guidelines for Determining Patent Infringement

  • MMLC Group
  • -
  • China
  • -
  • November 11 2013

Beijing High People's Court issued Guidelines for Determining Patent Infringement on 4 September 2013, replacing the Opinions on Several Issues

Enforcing patent rights in China

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia, China
  • -
  • May 15 2013

Australian companies increasingly elect to have their products manufactured in China, often to offset the costs associated with domestic manufacture

Changing trends in patent protection for the pharma industry

  • Heskia - Hacmun Law Firm
  • -
  • China, India, Israel
  • -
  • June 6 2013

This April India's Supreme Court oversaw a high profile case involving Novartis' patent application for Glivec, a cancer-battling medication

Civil litigation involving patent disputes

  • HFG Law Firm & Intellectual Property Practice
  • -
  • China
  • -
  • April 30 2013

Civil Litigation involving patent disputes shall be heard by competent intermediate courts designated by the Supreme Court. The administrative

Honda successfully challenges two lower courts’ decisions concerning the validity of a design patent for a SUV

  • Hogan Lovells
  • -
  • China
  • -
  • July 21 2011

The PRC Supreme Court accepted Honda’s application for a retrial and upheld the validity of its design patent for a SUV

US company hit by 800,000 USD damage compensation for abusing of an invalid patent

  • HFG Law Firm & Intellectual Property Practice
  • -
  • China
  • -
  • August 9 2013

Rohm and Haas Company, a large American company operating in the material and chemical sector, registered several patents on the technology of fruit

The second annual report on IP cases of the Supreme People’s Court of China

  • Foley & Lardner LLP
  • -
  • China
  • -
  • July 15 2010

On April 22, 2010, the Supreme People's Court (SPC) of China issued its annual report on intellectual property (IP) cases